FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Hirmand Mohammad

2. Date of Event Requiring Statement (MM/DD/YYYY)
9/29/2015 

3. Issuer Name and Ticker or Trading Symbol

MEDIVATION, INC. [MDVN]

(Last)        (First)        (Middle)

C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Interim Chief Medical Officer /

(Street)

SAN FRANCISCO, CA 94105       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   31230   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)     (1) 2/28/2018   Common Stock   5620   $4.0025   D    
Stock Option (Right to Buy)     (1) 10/31/2018   Common Stock   11940   $4.6925   D    
Stock Option (Right to Buy)     (1) 12/15/2019   Common Stock   24000   $8.64   D    
Stock Option (Right to Buy)     (1) 12/31/2020   Common Stock   60000   $3.7925   D    
Stock Option (Right to Buy)     (2) 12/17/2022   Common Stock   16880   $27.43   D    
Stock Appreciation Rights     (3) 1/3/2022   Common Stock   58800   $11.5975   D    
Stock Option (Right to Buy)     (2) 2/28/2024   Common Stock   11740   $35.955   D    
Stock Option (Right to Buy)     (2) 10/31/2024   Common Stock   3460   $52.85   D    
Stock Option (Right to Buy)     (2) 3/2/2025   Common Stock   13560   $60.525   D    

Explanation of Responses:
( 1)  Fully vested.
( 2)  The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) shall vest on the first anniversary of the date of grant, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) shall vest on the first day of each full month thereafter.
( 3)  The security shall become vested according to the following schedule: 25% of the shares subject to the security (rounded down to the next whole number of shares) shall vest on January 3, 2013, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) shall vest on the first day of each full month thereafter.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Hirmand Mohammad
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO, CA 94105

Interim Chief Medical Officer

Signatures
/s/ Rick Bierly, Attorney-in-fact 10/1/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Medivation, Inc. (MM) (NASDAQ:MDVN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Medivation, Inc. (MM) Charts.
Medivation, Inc. (MM) (NASDAQ:MDVN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Medivation, Inc. (MM) Charts.